Director/PDMR Shareholding
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your DXRX notes
Belfast and London, 23 May 2024 - Diaceutics PLC (AIM: DXRX) ("Diaceutics" or the "Company"), a leading technology and solutions provider to the pharma and biotech industry announces that on 22 May 2024, Graham Paterson, a Non-Executive Director of Diaceutics, purchased 39,934 ordinary shares of £0.002 each in the Company ("Ordinary Shares") at a price of £1.2889 per Ordinary Share. As a result of the purchase, Graham Paterson's shareholding in Diaceutics is 73,498 Ordinary Shares representing approximately 0.09% of the Company's issued share capital.
| a. | Name | Graham Paterson |
| 2 | Reason for notification | |
| a. | Position/Status | Non-Executive Director |
| b. | Initial notification/ Amendment | Initial |
| a. | Name | Diaceutics PLC |
| b. | LEI | 213800VEWQBB39ZB8J81 |
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary shares of £0.002 each ISIN: GB00BJQTGV64 |
| b. | Nature of the transaction | Purchase |
| c. | Price(s) and volume(s) | Share purchase: |
| Price(s) | Volume(s) | |
| £1.2889 | 39,934 | |
| d. | Date of the transaction | 22 May 2024 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.